Pulmatrix (PULM) Restructuring Costs (2019)
Pulmatrix's (PULM) quarterly Restructuring Costs came in at $200000.0 in Q1 2019.
Powered by 
Analysis
Pulmatrix (PULM) Restructuring Costs (2019) Analysis & Trends
Pulmatrix has disclosed Restructuring Costs across 1 years of filings, most recently posting $200000.0 for Q1 2019.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 639.77 Bn | 619.01 Bn | 17.26 Bn |
| 2 | AbbVie | 445.75 Bn | 439.18 Bn | 12.70 Bn |
| 3 | Merck | 356.51 Bn | 349.37 Bn | 12.21 Bn |
| 4 | Novartis Ag | 268.75 Bn | 261.06 Bn | 11.24 Bn |
| 5 | Pfizer | 156.41 Bn | 144.71 Bn | 10.94 Bn |
| 6 | Sanofi | 52.11 Bn | 44.73 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 43.22 Bn | 43.22 Bn | - |
| 8 | Incyte | 24.88 Bn | 20.34 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.31 Bn | 18.65 Bn | 683.80 Mn |
| 10 | Pulmatrix | 5.11 Mn | 5.11 Mn | - |